AR013492A1 - VETERINARY MEDICINAL PRODUCT CONTAINING THE NATIVE OR MODIFIED EQUINE CHORIOGONADOTROPHINE TO INDUCE OVULATION IN THE YEGUA AND TO STIMULATE THE DETESTOSTERONE PRODUCTION IN THE STALLION. - Google Patents

VETERINARY MEDICINAL PRODUCT CONTAINING THE NATIVE OR MODIFIED EQUINE CHORIOGONADOTROPHINE TO INDUCE OVULATION IN THE YEGUA AND TO STIMULATE THE DETESTOSTERONE PRODUCTION IN THE STALLION.

Info

Publication number
AR013492A1
AR013492A1 ARP980104580A ARP980104580A AR013492A1 AR 013492 A1 AR013492 A1 AR 013492A1 AR P980104580 A ARP980104580 A AR P980104580A AR P980104580 A ARP980104580 A AR P980104580A AR 013492 A1 AR013492 A1 AR 013492A1
Authority
AR
Argentina
Prior art keywords
native
stallion
stimulate
production
yegua
Prior art date
Application number
ARP980104580A
Other languages
Spanish (es)
Original Assignee
Inra Inst Nat De La Rech Agronomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inra Inst Nat De La Rech Agronomique filed Critical Inra Inst Nat De La Rech Agronomique
Publication of AR013492A1 publication Critical patent/AR013492A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion tiene como objetivo un medicamento veterinario para inducir la ovulacion en la yegua o estimular la produccion de testosterona en el semental,que contiene, como principio activo, la coriogonadotrofina equina (eCG) nativa o por lo menosuna forma de eCG modificada que, por lo menos en parte, estádesprovista de las estructuras glicánicas de tipo poli-(N-acetil-lactosamina) de la hormona nativa, o una mezclas de estas.The invention aims at a veterinary medicine to induce ovulation in the mare or stimulate the production of testosterone in the stallion, which contains, as active ingredient, the native equine choriogonadotropin (eCG) or at least one form of modified eCG that, for at least in part, it is devoid of the poly (N-acetyl-lactosamine) glycan structures of the native hormone, or a mixture thereof.

ARP980104580A 1997-09-19 1998-09-15 VETERINARY MEDICINAL PRODUCT CONTAINING THE NATIVE OR MODIFIED EQUINE CHORIOGONADOTROPHINE TO INDUCE OVULATION IN THE YEGUA AND TO STIMULATE THE DETESTOSTERONE PRODUCTION IN THE STALLION. AR013492A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9711720A FR2768627B1 (en) 1997-09-19 1997-09-19 VETERINARY MEDICINAL PRODUCT CONTAINING MODIFIED EQUINE CHORIOGONADOTROPIN TO INDUCE OVULATION IN THE MARE AND STIMULATE THE PRODUCTION OF TESTOSTERONE IN THE STANDARD

Publications (1)

Publication Number Publication Date
AR013492A1 true AR013492A1 (en) 2000-12-27

Family

ID=9511293

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980104580A AR013492A1 (en) 1997-09-19 1998-09-15 VETERINARY MEDICINAL PRODUCT CONTAINING THE NATIVE OR MODIFIED EQUINE CHORIOGONADOTROPHINE TO INDUCE OVULATION IN THE YEGUA AND TO STIMULATE THE DETESTOSTERONE PRODUCTION IN THE STALLION.

Country Status (6)

Country Link
EP (1) EP1015018A1 (en)
AR (1) AR013492A1 (en)
AU (1) AU9167898A (en)
FR (1) FR2768627B1 (en)
WO (1) WO1999015195A1 (en)
ZA (1) ZA988569B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ542549A (en) 2003-03-04 2008-11-28 Aspenbio Pharma Inc Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using single-chain luteinizing hormone
US8445431B2 (en) 2004-06-01 2013-05-21 The Ohio State University Ligands having metal binding ability and targeting properties
US8582837B2 (en) 2007-12-31 2013-11-12 Authentec, Inc. Pseudo-translucent integrated circuit package
CN109364240B (en) * 2018-08-30 2021-09-21 宁波三生生物科技股份有限公司 Pregnant mare serum gonadotropin freeze-dried powder and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260421A (en) * 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
JP2899534B2 (en) * 1994-12-09 1999-06-02 全国農業協同組合連合会 Method of inducing superovulation in cattle

Also Published As

Publication number Publication date
WO1999015195A1 (en) 1999-04-01
ZA988569B (en) 1999-03-30
EP1015018A1 (en) 2000-07-05
FR2768627A1 (en) 1999-03-26
FR2768627B1 (en) 2000-03-24
AU9167898A (en) 1999-04-12

Similar Documents

Publication Publication Date Title
CL2004000674A1 (en) TRANSDERMAL THERAPEUTIC SYSTEM THAT UNDERSTANDS AT LEAST AN ACTIVE PHARMACEUTICAL SUBSTANCE, AT LEAST A STRUCTURE DISRUPTOR AND / OR AT LEAST A STRUCTURE FORMATOR IN A COMMON MATRIX.
CL2009000648A1 (en) Propeptide bmp-11 modified at residue 98 of a human bmp-11 sequence; nucleic acid that encodes it; pharmaceutical composition comprising it; method of preparing the propeptide, recombinant cell; use of the propeptide to treat muscular, neuromuscular, metabolic, and degenerative bone disorders (divisional sol.224-02).
AR032132A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMBINATION OF A TRAMADOL COMPOUND AND ANTI-CONVULSIVE DRUG AND USE OF THE COMBINATION TO PREPARE A MEDICINAL PRODUCT
ES2077530B1 (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL PRODUCTS TO CURE TUMOR DISEASES.
ES2190244T3 (en) USE OF THE PARTIROID HORMONE CONSTITUTED BY A SEQUENCE OF AMINO ACIDS 1-34 OF THE HUMAN PARTIROID HORMONE TO REDUCE THE RISK OF VERTEBRAL AND NON-VERTEBRAL BONE FRACTURES.
ES2126536B1 (en) "PHARMACEUTICAL PREPARATION FOR INTRANASAL ADMINISTRATION AND PROCEDURE FOR ITS PRODUCTION".
ES2191329T3 (en) USE OF XANTOFILS IN MEDICINES FOR THE IMPROVEMENT OF THE DURATION OF MUSCLE FUNCTION OR THE TREATMENT OF DISORDERS OR MUSCULAR DISEASES.
UY26130A1 (en) COMPOUNDS TO TREAT OBESITY
AR036378A1 (en) AN ABSORBENT DEVICE ADAPTED TO DELIVER A THERAPEUTIC AGENT AND THE METHOD TO PRODUCE SUCH DEVICE
UY28213A1 (en) NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS.
PT90764A (en) Process for the preparation of a pharmaceutical product comprising a sterol and an anti-estrogen and of pharmaceutical compositions containing the same
BR9910583A (en) Non-substituted aminotetralins as binders for the neuropeptide receptor y5 useful in the treatment of obesity and other disorders
ES2167717T3 (en) NEW CYCLICAL AMINO ACIDS REPLACED AS PHARMACEUTICAL AGENTS.
BR0110486A (en) Anthanilamides and their application as a medicine
BR0110621A (en) Orthosubstituted anthranic acid amides and their use as a medicine
CL2008003938A1 (en) Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
ECSP044961A (en) ACID N- (5-CHLOROSALICILOIL) -8-AMINOCAPRILICO AS AN ORAL SUPPLY AGENT FOR PARTIROID HORMONE FRAGMENTS
ATE289293T1 (en) SUBSTITUTED AMINOALKYLAMIDE DERIVATIVES AS ANTAGONISTS OF FOLLICLE-STIMULATING HORMONE
AR013492A1 (en) VETERINARY MEDICINAL PRODUCT CONTAINING THE NATIVE OR MODIFIED EQUINE CHORIOGONADOTROPHINE TO INDUCE OVULATION IN THE YEGUA AND TO STIMULATE THE DETESTOSTERONE PRODUCTION IN THE STALLION.
BR9912223A (en) Therapeutic agent for hypercalcemic crisis
BR9916190A (en) Use of kqt1 channel inhibitors for the preparation of a medicine for the treatment of diseases, which are caused by helminths and ectoparasites
ES2101317T3 (en) MEDICATION TO INCREASE THE TESTOSTERONE LEVEL.
AR021086A1 (en) OMEGA-AMIDAS OF N-ARILSULFONIL-AMINO ACIDS, A PROCEDURE FOR THE PREPARATION, MEDICATION, USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT AND PROCEDURE FOR THE PREPARATION OF A MEDICINAL PRODUCT.
ES2177671T3 (en) ENTERZINETIC BENZAMIDE.
BR0116653A (en) Medicinal product containing a polyamine as active substance

Legal Events

Date Code Title Description
FA Abandonment or withdrawal